Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to enter its third Latin American market this year, following earlier expansions into Argentina and Peru.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and regulatory compliance before broader market deployment.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
Nanox aims to drive the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Its vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox seeks to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
This expansion into Costa Rica matters because it signifies Nanox's growing footprint in Latin America, a region where access to advanced medical imaging can be limited. By partnering with a local distributor that is already a registered supplier to the CCSS, Nanox is strategically positioned to integrate its technology into the public healthcare system. The proof-of-concept registration period suggests a careful approach to regulatory and clinical adoption, which could serve as a model for future market entries. For investors, this agreement demonstrates Nanox's ability to execute its global commercialization strategy, potentially driving revenue growth and reinforcing its position in the preventive healthcare market. For the medical imaging industry, it highlights the increasing role of AI and cloud-based solutions in expanding access to care. Patients in Costa Rica may eventually benefit from earlier detection of diseases through more accessible 3D imaging, aligning with Nanox's mission to improve patient outcomes worldwide. To view the full press release, visit https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
